Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib and Pembrolizumab in mGC
NCT04164979Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Feb 2020
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in gastric adenocarcinoma, gastroesophageal adenocarcinoma, sponsored by University of California, Irvine. Started Feb 2020; status: completed.
02
Drugs
cabozantinib
03
Conditions
gastric adenocarcinomagastroesophageal adenocarcinoma
Beyond the preview
Go deeper on NCT04164979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04164979.